Oxcarbazepine

ApprovedCompleted

2 views this week 0 watching⚡ Active

Interest: 43/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

✓

Phase 3

Approved

Indication / Disease

Epilepsy, Partial Seizures

Conditions

Epilepsy, Partial Seizures

Trial Timeline

Sep 11, 2006 → Sep 28, 2007

NCT ID

NCT00275912

About Oxcarbazepine

Oxcarbazepine is a approved stage product being developed by Novartis for Epilepsy, Partial Seizures. The current trial status is completed. This product is registered under clinical trial identifier NCT00275912. Target conditions include Epilepsy, Partial Seizures.

What happened to similar drugs?

20 of 20 similar drugs in Epilepsy, Partial Seizures were approved

Approved (20) Terminated (6) Active (0)

✅ZonegranEisaiApproved

✅Perampanel + PlaceboEisaiApproved

✅perampanelEisaiApproved

✅Perampanel Oral TabletEisaiApproved

✅PerampanelEisaiApproved

✅zonisamide low dose group + zonisamide high dose groupEisaiApproved

✅Zonisamide at targeted daily doses of 100-500 mg/day + Placebo administered to match targeted daily doses of 100-500 mg/dayEisaiApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (6)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00275912	Approved	Completed	Sep 11, 2006	Sep 28, 2007	Epilepsy, Partial Seizures
NCT00275925	Approved	Completed	Dec 1, 2005	Mar 1, 2007	Epilepsy, Partial Seizures
NCT00154362	Approved	Completed	Apr 1, 2003	Oct 1, 2004	Conduct Disorder
NCT00154323	Approved	Completed	Jan 1, 2003	Jan 1, 2006	Bipolar Disorder
NCT00050947	Phase 3	Completed	Jul 1, 2002	Feb 1, 2004	Epilepsy
NCT00050934	Phase 3	Completed	Jun 1, 2002	Jun 1, 2004	Epilepsy

Competing Products

20 competing products in Epilepsy, Partial Seizures

See all competitors

Product	Company	Stage	Hype Score
perampanel	Eisai	Phase 2	35
Lacosamide	UCB	Phase 3	40
Zonisamide + Placebo	Eisai	Phase 3	32
Zonegran	Eisai	Approved	35
perampanel + perampanel	Eisai	Phase 1	29
Perampanel + Placebo	Eisai	Approved	35
perampanel	Eisai	Approved	35
E2007 + Placebo	Eisai	Phase 2	35
Placebo + Rufinamide	Eisai	Phase 3	40
E2007 (perampanel) + Placebo	Eisai	Phase 2	35
Perampanel Oral Tablet	Eisai	Approved	43
perampanel	Eisai	Phase 3	40
Perampanel	Eisai	Pre-clinical	26
Zonisamide + Carbamazepine	Eisai	Phase 3	40
Perampanel	Eisai	Approved	43
Perampanel and Microgynon-30 + Perampanel and Microgynon-30	Eisai	Phase 1	29
Perampanel	Eisai	Phase 2	35
Zonisamide + Placebo	Eisai	Phase 3	40
zonisamide low dose group + zonisamide high dose group	Eisai	Approved	43
E2007 + E2007 + Placebo	Eisai	Phase 2	35